According to Ionis Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -ยฃ2.22. In 2022 the company made an earnings per share (EPS) of -ยฃ1.47 a decrease over its 2021 EPS that were of -ยฃ0.15.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -ยฃ2.33 | 58.72% |
2022 | -ยฃ1.47 | 850% |
2021 | -ยฃ0.15 | -93.51% |
2020 | -ยฃ2.38 | -245.28% |
2019 | ยฃ1.64 | 6.53% |
2018 | ยฃ1.54 | 3880% |
2017 | ยฃ0.03860 | -106.94% |
2016 | -ยฃ0.56 | -1.37% |
2015 | -ยฃ0.56 | 114.71% |
2014 | -ยฃ0.26 | -35.85% |
2013 | -ยฃ0.41 | -18.46% |
2012 | -ยฃ0.50 | -23.53% |
2011 | -ยฃ0.66 | 37.1% |
2010 | -ยฃ0.48 | -138.99% |
2009 | ยฃ1.23 | -936.84% |
2008 | -ยฃ0.15 | -88.13% |
2007 | -ยฃ1.24 | 162.3% |
2006 | -ยฃ0.47 | -47.86% |
2005 | -ยฃ0.90 | -53.57% |
2004 | -ยฃ1.95 | 46.51% |
2003 | -ยฃ1.33 | 27.41% |
2002 | -ยฃ1.04 | -21.51% |
2001 | -ยฃ1.33 | 13.91% |
2000 | -ยฃ1.17 | -27.4% |
1999 | -ยฃ1.61 | 29.19% |
1998 | -ยฃ1.24 | 36.44% |
1997 | -ยฃ0.91 | 13.46% |
1996 | -ยฃ0.80 |